Featured Posters & Presentations
Lyfgenia
LentiGlobin gene therapy in patients with sickle cell disease: Updated interim results from HGB-206.
Authors: Mapara MY.
Zynteglo
Long-term safety and efficacy of lentiglobin gene therapy in patients with transfusion-dependent β-thalassemia following completion of the phase 1/2 northstar study.
Authors: Hongeng S.
Zynteglo
Updated results from the ongoing northstar-2 (HGB-207) trial of lentiglobin gene therapy in patients with transfusion-dependent β-thalassemia and non-β0/β0 genotypes.
Authors: Locatelli F.